Product Code: ETC13371206 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Veterinary CDMO Market was valued at USD 2.1 Billion in 2024 and is expected to reach USD 3.4 Billion by 2031, growing at a compound annual growth rate of 5.90% during the forecast period (2025-2031).
The Global Veterinary Contract Development and Manufacturing Organization (CDMO) Market is witnessing significant growth driven by the increasing demand for specialized veterinary pharmaceuticals and biologics. CDMOs offer various services including formulation development, manufacturing, packaging, and regulatory support to veterinary drug companies, enabling them to outsource these processes and focus on core competencies. Factors such as the rising pet adoption rates, increasing awareness about animal health, and the growing prevalence of zoonotic diseases are contributing to the expansion of the veterinary CDMO market. Additionally, advancements in biotechnology and the emergence of personalized medicine for animals are further fueling market growth. Key players in the industry are actively investing in expanding their capabilities and geographical presence to cater to the evolving needs of the veterinary pharmaceutical sector.
The Global Veterinary CDMO (Contract Development and Manufacturing Organization) Market is experiencing significant growth due to the increasing demand for specialized veterinary products and services. Key trends include the rise in outsourcing of veterinary drug development and manufacturing by pharmaceutical companies, the emergence of innovative therapies for companion animals, and the expansion of CDMOs` capabilities to meet the evolving needs of the veterinary industry. Opportunities in the market are abundant for CDMOs that can offer tailored solutions, high-quality services, and efficient production processes to support the development of novel veterinary drugs and vaccines. Additionally, the growing focus on personalized medicine for animals presents a promising avenue for CDMOs to collaborate with veterinary researchers and companies in developing customized treatment options. Overall, the Global Veterinary CDMO Market is poised for continued growth and innovation in the coming years.
In the Global Veterinary CDMO (Contract Development and Manufacturing Organization) Market, some of the key challenges faced include stringent regulatory requirements for veterinary pharmaceuticals, limited accessibility of specialized infrastructure and technology, increasing competition from in-house manufacturing capabilities of large pharmaceutical companies, and the complexity of managing diverse product portfolios for multiple clients. Additionally, the market is witnessing a shift towards more personalized and specialized treatments for animals, requiring CDMOs to adapt and invest in advanced technologies and expertise. Furthermore, fluctuations in raw material costs, changing market dynamics, and the need for continuous innovation to meet evolving customer demands are also significant challenges that veterinary CDMOs must address to stay competitive in the market.
The Global Veterinary CDMO (Contract Development and Manufacturing Organization) Market is primarily driven by the increasing demand for specialized pharmaceuticals and biologics for veterinary use. As the complexity of veterinary drug development and manufacturing processes grows, many companies are outsourcing these services to CDMOs to leverage their expertise and infrastructure, driving market growth. Additionally, the rising focus on animal health and welfare, along with the increasing prevalence of zoonotic diseases, further propels the demand for high-quality veterinary pharmaceuticals. Moreover, CDMOs offer cost-effective solutions, flexible manufacturing capacities, and accelerated timelines, which are attractive to veterinary drug developers. Overall, the expansion of the global veterinary CDMO market is fueled by the need for innovative and efficient solutions to meet the evolving requirements of the veterinary pharmaceutical industry.
Government policies related to the Global Veterinary CDMO (Contract Development and Manufacturing Organization) Market primarily focus on ensuring the safety, efficacy, and quality of veterinary pharmaceuticals and biologics. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the European Union have established guidelines and standards that CDMOs must adhere to in order to operate in the market. These policies include requirements for Good Manufacturing Practices (GMP), quality control measures, and thorough testing procedures to protect animal health and well-being. Additionally, governments may incentivize research and development in the veterinary pharmaceutical sector through funding programs or tax credits to encourage innovation and the development of new products to address emerging animal health challenges.
The Global Veterinary CDMO (Contract Development and Manufacturing Organization) Market is poised for significant growth in the coming years due to the increasing demand for specialized pharmaceutical and biopharmaceutical products in the veterinary industry. Factors such as the rising prevalence of animal diseases, the growing adoption of companion animals, and the need for innovative treatment solutions are driving the expansion of this market. Additionally, advancements in technology and the shift towards personalized medicine for animals are expected to further propel the growth of the Veterinary CDMO market. As more companies outsource their drug development and manufacturing processes to CDMOs to streamline operations and reduce costs, the market is forecasted to experience substantial growth and opportunities for expansion globally.
In the Global Veterinary CDMO (Contract Development and Manufacturing Organization) Market, Asia is emerging as a key region due to the increasing pet adoption rates and rising focus on animal health. North America leads the market with a well-established veterinary pharmaceutical industry and a high level of investment in research and development. Europe follows closely behind, driven by the presence of prominent players and a growing demand for specialized veterinary services. The Middle East and Africa region is witnessing steady growth in the veterinary CDMO market, supported by improving healthcare infrastructure and rising awareness about animal welfare. Latin America is also showing promising growth potential, with a growing livestock industry and increasing investments in animal healthcare. Overall, the global veterinary CDMO market is dynamic and evolving, with each region presenting unique opportunities and challenges for market players.
Global Veterinary CDMO Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Veterinary CDMO Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Veterinary CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Global Veterinary CDMO Market - Industry Life Cycle |
3.4 Global Veterinary CDMO Market - Porter's Five Forces |
3.5 Global Veterinary CDMO Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Veterinary CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.7 Global Veterinary CDMO Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Global Veterinary CDMO Market Revenues & Volume Share, By Animal Type, 2021 & 2031F |
3.9 Global Veterinary CDMO Market Revenues & Volume Share, By Manufacturing Process, 2021 & 2031F |
3.10 Global Veterinary CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Veterinary CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Veterinary CDMO Market Trends |
6 Global Veterinary CDMO Market, 2021 - 2031 |
6.1 Global Veterinary CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Veterinary CDMO Market, Revenues & Volume, By Contract Development, 2021 - 2031 |
6.1.3 Global Veterinary CDMO Market, Revenues & Volume, By Contract Manufacturing, 2021 - 2031 |
6.2 Global Veterinary CDMO Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Veterinary CDMO Market, Revenues & Volume, By Vaccines, 2021 - 2031 |
6.2.3 Global Veterinary CDMO Market, Revenues & Volume, By APIs, 2021 - 2031 |
6.3 Global Veterinary CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Veterinary CDMO Market, Revenues & Volume, By Companion Animals, 2021 - 2031 |
6.3.3 Global Veterinary CDMO Market, Revenues & Volume, By Livestock, 2021 - 2031 |
6.4 Global Veterinary CDMO Market, Revenues & Volume, By Manufacturing Process, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Veterinary CDMO Market, Revenues & Volume, By Small Molecule, 2021 - 2031 |
6.4.3 Global Veterinary CDMO Market, Revenues & Volume, By Biologics, 2021 - 2031 |
6.5 Global Veterinary CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Veterinary CDMO Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.5.3 Global Veterinary CDMO Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
7 North America Veterinary CDMO Market, Overview & Analysis |
7.1 North America Veterinary CDMO Market Revenues & Volume, 2021 - 2031 |
7.2 North America Veterinary CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Veterinary CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.4 North America Veterinary CDMO Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.5 North America Veterinary CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
7.6 North America Veterinary CDMO Market, Revenues & Volume, By Manufacturing Process, 2021 - 2031 |
7.7 North America Veterinary CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Veterinary CDMO Market, Overview & Analysis |
8.1 Latin America (LATAM) Veterinary CDMO Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Veterinary CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Veterinary CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
8.4 Latin America (LATAM) Veterinary CDMO Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
8.5 Latin America (LATAM) Veterinary CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
8.6 Latin America (LATAM) Veterinary CDMO Market, Revenues & Volume, By Manufacturing Process, 2021 - 2031 |
8.7 Latin America (LATAM) Veterinary CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Veterinary CDMO Market, Overview & Analysis |
9.1 Asia Veterinary CDMO Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Veterinary CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Veterinary CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
9.4 Asia Veterinary CDMO Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
9.5 Asia Veterinary CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
9.6 Asia Veterinary CDMO Market, Revenues & Volume, By Manufacturing Process, 2021 - 2031 |
9.7 Asia Veterinary CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Veterinary CDMO Market, Overview & Analysis |
10.1 Africa Veterinary CDMO Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Veterinary CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Veterinary CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
10.4 Africa Veterinary CDMO Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
10.5 Africa Veterinary CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
10.6 Africa Veterinary CDMO Market, Revenues & Volume, By Manufacturing Process, 2021 - 2031 |
10.7 Africa Veterinary CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Veterinary CDMO Market, Overview & Analysis |
11.1 Europe Veterinary CDMO Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Veterinary CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Veterinary CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
11.4 Europe Veterinary CDMO Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
11.5 Europe Veterinary CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
11.6 Europe Veterinary CDMO Market, Revenues & Volume, By Manufacturing Process, 2021 - 2031 |
11.7 Europe Veterinary CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Veterinary CDMO Market, Overview & Analysis |
12.1 Middle East Veterinary CDMO Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Veterinary CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Veterinary CDMO Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Veterinary CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
12.4 Middle East Veterinary CDMO Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
12.5 Middle East Veterinary CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
12.6 Middle East Veterinary CDMO Market, Revenues & Volume, By Manufacturing Process, 2021 - 2031 |
12.7 Middle East Veterinary CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Veterinary CDMO Market Key Performance Indicators |
14 Global Veterinary CDMO Market - Export/Import By Countries Assessment |
15 Global Veterinary CDMO Market - Opportunity Assessment |
15.1 Global Veterinary CDMO Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Veterinary CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F |
15.3 Global Veterinary CDMO Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
15.4 Global Veterinary CDMO Market Opportunity Assessment, By Animal Type, 2021 & 2031F |
15.5 Global Veterinary CDMO Market Opportunity Assessment, By Manufacturing Process, 2021 & 2031F |
15.6 Global Veterinary CDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Veterinary CDMO Market - Competitive Landscape |
16.1 Global Veterinary CDMO Market Revenue Share, By Companies, 2024 |
16.2 Global Veterinary CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |